A detailed history of Aviva PLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Aviva PLC holds 1,785 shares of MEDP stock, worth $624,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,785
Previous 1,592 12.12%
Holding current value
$624,821
Previous $655,000 9.16%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$320.58 - $457.29 $61,871 - $88,256
193 Added 12.12%
1,785 $595,000
Q2 2024

Aug 02, 2024

BUY
$372.0 - $424.34 $9,300 - $10,608
25 Added 1.6%
1,592 $655,000
Q1 2024

May 14, 2024

SELL
$284.87 - $413.31 $168,073 - $243,852
-590 Reduced 27.35%
1,567 $633,000
Q4 2023

Feb 09, 2024

SELL
$227.52 - $312.68 $30,487 - $41,899
-134 Reduced 5.85%
2,157 $661,000
Q3 2023

Nov 13, 2023

SELL
$233.98 - $281.67 $990,905 - $1.19 Million
-4,235 Reduced 64.89%
2,291 $554,000
Q2 2023

Aug 10, 2023

SELL
$187.26 - $240.17 $243,812 - $312,701
-1,302 Reduced 16.63%
6,526 $1.57 Million
Q1 2023

May 12, 2023

BUY
$174.31 - $239.52 $527,636 - $725,027
3,027 Added 63.05%
7,828 $1.47 Million
Q4 2022

Feb 09, 2023

SELL
$153.06 - $226.57 $817,187 - $1.21 Million
-5,339 Reduced 52.65%
4,801 $1.02 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $603,450 - $758,793
-4,158 Reduced 29.08%
10,140 $1.59 Million
Q2 2022

Aug 04, 2022

BUY
$130.2 - $168.03 $64,839 - $83,678
498 Added 3.61%
14,298 $2.14 Million
Q1 2022

May 13, 2022

BUY
$138.87 - $214.31 $240,939 - $371,827
1,735 Added 14.38%
13,800 $2.26 Million
Q4 2021

Feb 10, 2022

BUY
$182.74 - $227.9 $607,793 - $757,995
3,326 Added 38.06%
12,065 $2.63 Million
Q3 2021

Nov 12, 2021

BUY
$170.18 - $198.21 $1.49 Million - $1.73 Million
8,739 New
8,739 $1.65 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.9B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.